{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:17:52Z","timestamp":1793506672004,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Russian University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A new drug combination of phenylephrine hydrochloride (PHE) and doxylamine succinate (DOX) has been introduced for treating allergic rhinitis. Stability testing is critical for uncovering degradation routes and assessing the stability of combined drugs. This study illustrates the application of two eco-friendly chromatographic techniques which are reversed phase high-performance liquid chromatography (RP-HPLC) and high-performance thin-layer chromatography (HPTLC), for assessing PHE and DOX when DOX oxidative degradation product (DOX DEG) is present. Using liquid chromatography- mass spectroscopy to identify DOX DEG. The HPLC method produced the best separation with isocratic elution and a mobile phase consists of ethanol and 0.01\u00a0M phosphate buffer pH\u2009=\u20095.0 (30: 70, v\/v), and it was pumped at 1.0 mL\/min. The analytes were measured at 260.0\u00a0nm using diode array detector (DAD), and the Xterra C\n                    <jats:sub>18<\/jats:sub>\n                    column (100\u00a0mm \u00d7 4.6\u00a0mm \u00d7 5\u00a0m) used as a stationary phase. The method demonstrated a linear response for DOX and PHE across a concentration range of 5.00 to 100.00\u00a0\u00b5g\/mL. The range for DOX DEG was 5.00 to 30.00\u00a0\u00b5g\/mL. The limits of detection (LOD) were determined to be 1.44 for DOX, 1.59 for PHE, and 0.84\u00a0\u00b5g\/mL for DOX DEG. Correspondingly, the limits of quantification (LOQ) were 4.32, 4.77, and 2.52\u00a0\u00b5g\/mL for DOX, PHE, and DOX DEG, respectively. The separation in HPTLC was accomplished by combining ethanol, methylene chloride, and ammonia 30% in ratio 7:2.5:0.5 (v\/v\/v) as a developing system. The drugs were then quantitatively determined at wavelengths of 260.0\u00a0nm using UV detector. The linearity range was 4.00\u201326.00 (\u00b5g\/band) for DOX and PHE while it was 0.50\u201310.00 (\u00b5g\/band) for DOX DEG. Values of LOD were 0.65 ,0.76 and 0.16\u00a0\u00b5g\/band for PHE, DOX, DOX DEG, respectively. While1.95,2.28 and 0.48\u00a0\u00b5g\/band were values of LOQ. Per ICH guidelines, two analytical methods were validated and proven to be reliable, reproducible, and selective. Additionally, sustainability assessments confirmed their green credentials and practical applicability.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-22295-6","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:30:31Z","timestamp":1761229831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Two sustainable chromatographic approaches for estimation of new combination of phenylephrine hydrochloride and doxylamine succinate in presence of doxylamine oxidative degradation product"],"prefix":"10.1038","volume":"15","author":[{"given":"Heidi R.","family":"Abd El-Hadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"22295_CR1","first-page":"32","volume":"62","author":"HR Abd El-Hadi","year":"2024","unstructured":"Abd El-Hadi, H. R., Eltanany, B. M., Zaazaa, H. E. & Eissa, M. S. Smart spectrophotometric approaches for Estimation of difluprednate in existence of its synthetic precursor and alkaline degradation product; comparative statistical studies and analytical ecological appraisal. Bull. Fac. Pharm. Cairo Univ. 62, 32\u201343 (2024).","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"key":"22295_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-96091-7","volume":"15","author":"HR Abd El-Hadi","year":"2025","unstructured":"Abd El-Hadi, H. R. Comparative statistical evaluation of greenness, blueness, and whiteness spectrophotometric methods for dexamethasone and Chloramphenicol Estimation. Sci. Rep. 15, 1\u201312 (2025).","journal-title":"Sci. Rep."},{"key":"22295_CR3","doi-asserted-by":"crossref","unstructured":"Aljeboree, A. M. & Alshirifi, A. N. Determination of phenylephrine hydrochloride and amoxicillin in binary mixture using derivative spectrophotometry methods. Int. J. Pharm. Qual. Assur. 10 (2019).","DOI":"10.25258\/ijpqa.10.3.10"},{"key":"22295_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jaoacint\/qsac090","volume":"106","author":"HR Abd El-Hadi","year":"2022","unstructured":"Abd El-Hadi, H. R., Eltanany, B. M., Zaazaa, H. E. & Eissa, M. S. Chemometric quality assessment of Doxylamine succinate with its degradation product; implementation of two predictive models on uv-spectrophotometric data of anti-emetic binary mixture. J. AOAC Int. 106, 221\u2013227 (2022).","journal-title":"J. AOAC Int."},{"key":"22295_CR5","first-page":"1625","volume":"10","author":"SB Kanthale","year":"2019","unstructured":"Kanthale, S. B., Thonte, S. S. & Supekar, B. B. Development of stability indicating assay method: A review. Int. J. Pharm. Sci. Res. 10, 1625 (2019).","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"22295_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.talanta.2006.02.023","volume":"70","author":"JF Ventura-Gayete","year":"2006","unstructured":"Ventura-Gayete, J. F., de la Guardia, M. & Garrigues, S. On-line sample treatment and FT-IR determination of Doxylamine succinate in pharmaceuticals. Talanta 70, 1100\u20131106 (2006).","journal-title":"Talanta"},{"key":"22295_CR7","doi-asserted-by":"crossref","unstructured":"Harde, M. T. & Lakade, S. H. A stability-indicating HPLC method for estimation of Doxylamine succinate in tablets and characterization of its major alkaline stress degradation product. Futur. J. Pharm. Sci. 7, (2021).","DOI":"10.1186\/s43094-021-00276-6"},{"key":"22295_CR8","doi-asserted-by":"publisher","first-page":"106982","DOI":"10.1016\/j.microc.2021.106982","volume":"172","author":"HR Abd El-Hadi","year":"2021","unstructured":"Abd El-Hadi, H. R., Eltanany, B. M., Zaazaa, H. E. & Eissa, M. S. HPLC-DAD approach for determination of pyridoxine HCl and Doxylamine succinate in pure and pharmaceutical dosage forms: A green stability-indicating assay method. Microchem J. 172, 106982 (2021).","journal-title":"Microchem J."},{"key":"22295_CR9","first-page":"218","volume":"5","author":"PK Pradhan","year":"2014","unstructured":"Pradhan, P. K. & Upadhyay, U. M. Simultaneous Estimation of phenylephrine hcl, Doxylamine succinate and dextromethorphan Hbr in soft gelatin capsule (cough and cold preparation) by RP-HPLC. Int. J. Pharma Sci. Res. 5, 218\u2013225 (2014).","journal-title":"Int. J. Pharma Sci. Res."},{"key":"22295_CR10","doi-asserted-by":"crossref","unstructured":"Abd El-Hadi, H. R., Eissa, M. S., Zaazaa, H. E. & Eltanany, B. M. Chemometric quality assessment of Doxylamine succinate with its degradation product: implementation of two predictive models on uv-spectrophotometric data of anti-emetic binary mixture. J. AOAC Int. 1\u20137 (2022).","DOI":"10.1093\/jaoacint\/qsac090"},{"key":"22295_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.saa.2020.118489","volume":"239","author":"AM Yehia","year":"2020","unstructured":"Yehia, A. M., Nabil, M., Badawey, A. M. & Abbas, S. S. Spectral resolution of quaternary components in a sinus and congestion mixture; multivariate algorithms to approach extremes of concentration levels, Spectrochim. Acta - Part A mol. Biomol. Spectrosc. 239, 118\u2013189 (2020).","journal-title":"Biomol. Spectrosc."},{"key":"22295_CR12","doi-asserted-by":"crossref","unstructured":"Al-Uzri, W. A. Determination of phenylephrine hydrochloride in pharmaceutical preparations using spectrophotometric method. Asian J. Pharm. Clin. Res. 339\u2013343 (2019).","DOI":"10.22159\/ajpcr.2019.v12i5.32339"},{"key":"22295_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jscs.2009.12.004","volume":"14","author":"NH Al-Shaalan","year":"2010","unstructured":"Al-Shaalan, N. H. Determination of phenylephrine hydrochloride and Chlorpheniramine maleate in binary mixture using chemometric-assisted spectrophotometric and high-performance liquid chromatographic-UV methods. J. Saudi Chem. Soc. 14, 15\u201321 (2010).","journal-title":"J. Saudi Chem. Soc."},{"key":"22295_CR14","unstructured":"British & Pharmacopoeia Stationary Office, Appendix 1D, Buckingham Palace Road, London, UK, (2016)."},{"key":"22295_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00764-020-00055-8","volume":"33","author":"MS Eissa","year":"2020","unstructured":"Eissa, M. S., Abd El-Hadi, H. R., Zaazaa, H. E. & Eltanany, B. M. Smart TLC\u2013densitometric methods for determination of ophthalmic ternary mixture containing Chloramphenicol in the presence of its synthetic precursor: comparative eco-scaling for greenness assessment. J. Planar Chromatogr. - Mod. TLC. 33, 501\u2013509 (2020).","journal-title":"J. Planar Chromatogr. - Mod. TLC"},{"key":"22295_CR16","unstructured":"International Conference on Harmonisation. ICH Q1A(R2) Harmonised tripartite guideline, stability testing of new drug substances and products. (2003)."},{"key":"22295_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-023-01089-9","volume":"17","author":"HR Abd El-Hadi","year":"2023","unstructured":"Abd El-Hadi, H. R., Eissa, M. S., Zaazaa, H. E. & Eltanany, B. M. Development and validation of chemometric-assisted spectrophotometric models for efficient quantitation of a binary mixture of supportive treatments in COVID-19 in the presence of its toxic impurities: a comparative study for eco-friendly assessment. BMC Chem. 17, 1\u201316 (2023).","journal-title":"BMC Chem."},{"key":"22295_CR18","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1039\/b926439f","volume":"39","author":"M Tobiszewski","year":"2010","unstructured":"Tobiszewski, M., Mechlinska, A. & Namie, J. Green analytical chemistry\u2014theory and practice. Chem. Soc. Rev. 39, 2869\u20132878 (2010).","journal-title":"Chem. Soc. Rev."},{"key":"22295_CR19","doi-asserted-by":"publisher","first-page":"101075","DOI":"10.1016\/j.scp.2023.101075","volume":"33","author":"HR Abd El-Hadi","year":"2023","unstructured":"Abd El-Hadi, H. R., Eltanany, B. M., Zaazaa, H. E. & Eissa, M. S. Chromatographic impurity profile assessment of dual action binary combination: ecological analysis with comparative statistics. Sustain. Chem. Pharm. 33, 101075 (2023).","journal-title":"Sustain. Chem. Pharm."},{"key":"22295_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka, J. A new tool for the evaluation of the analytical procedure: green analytical procedure index. Talanta 181, 204\u2013209 (2018).","journal-title":"Talanta"},{"key":"22295_CR21","first-page":"1","volume":"4","author":"SA Atty","year":"2022","unstructured":"Atty, S. A., Abd El-Hadi, H. R., Eltanany, B. M., Zaazaa, H. E. & Eissa, M. S. Analytical eco \u2013 scale for evaluating the uniqueness of voltammetric method used for determination of antiemetic binary mixture containing Doxylamine succinate in presence of its toxic metabolite. Electrocatalysis 4, 1\u201316 (2022).","journal-title":"Electrocatalysis"},{"key":"22295_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-50600-8","volume":"14","author":"HR Abd El-Hadi","year":"2024","unstructured":"Abd El-Hadi, H. R., Eissa, M. S., Eltanany, B. M., Zaazaa, H. E. & Arafa, R. M. Greenness and whiteness assessment of a sustainable voltammetric method for difluprednate Estimation in the presence of its alkaline degradation product. Sci. Rep. 14, 1\u20139 (2024).","journal-title":"Sci. Rep."},{"key":"22295_CR23","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N., Wojnowski, W., P\u0142otka-Wasylka, J. & Samanidou, V. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green. Chem. 25, 7598\u20137604 (2023).","journal-title":"Green. Chem."},{"key":"22295_CR24","doi-asserted-by":"publisher","first-page":"106685","DOI":"10.1016\/j.microc.2021.106685","volume":"170","author":"KP Kannaiah","year":"2018","unstructured":"Kannaiah, K. P., Sugumaran, A., Chanduluru, H. K. & Rathinam, S. Environmental impact of greenness assessment tools in liquid chromatography \u2013 A review. Microchem J. 170, 106685 (2018).","journal-title":"Microchem J."},{"key":"22295_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph17081002","volume":"17","author":"HS AlSalem","year":"2024","unstructured":"AlSalem, H. S. et al. High performance thin layer chromatography (HPTLC) analysis of anti-asthmatic combination therapy in pharmaceutical formulation: assessment of the method\u2019s greenness and blueness. Pharmaceuticals 17, 1\u201318 (2024).","journal-title":"Pharmaceuticals"},{"key":"22295_CR26","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.52711\/0974-360X.2024.00435","volume":"17","author":"M Nouman","year":"2024","unstructured":"Nouman, M. Study the stability of pharmaceutical eye drop composed of Chloramphenicol and dexamethasone sodium phosphate stored in non-recommended conditions. Res. J. Pharm. Technol. 17, 2773\u20132777 (2024).","journal-title":"Res. J. Pharm. Technol."},{"key":"22295_CR27","doi-asserted-by":"crossref","unstructured":"Verma, H., Verma, S. & Singh, H. A. Stability indicating assay method development and validation for the frovatriptan succinate monohydrate by using uv: a spectrophotometric technique. ISRN Spectrosc. 2013 1\u20136 (2013).","DOI":"10.1155\/2013\/361385"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22295-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:30:35Z","timestamp":1761229835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22295-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22295"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22295-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37156"}}